MUSC Hollings Cancer Center

Frequently Asked Questions

1.    Do I have to pre-identify my mentors?
No. If you do not yet know what mentor team you would like to propose, please describe the advice and expertise you are seeking from potential mentors in the application form. Applicants who are currently affiliated with MUSC are encouraged to select their mentor team at the time of application.

2.    May I suggest a mentor who is not on the mentor list?
Yes. Other MUSC faculty members may be considered to be mentors on the K12 Paul Calabresi Career Development for Clinical & Translational Oncology Program. If you would like to propose a mentor who is not listed, contact to request approval of your proposed mentor. Note that primary mentors must meet the following requirements in order to be considered for approval:
     •  A long-standing track record of successful, independent research.
     •  Must have already obtained their own funding (e.g., R01).•
     •  Successful record of mentoring trainees in academic careers.
     •  Time to dedicate to a mentee.
     •  Desire to be a mentor and willingness to write a letter of support.

3.    How many Scholars will be selected for the K12 Paul Calabresi Career Development for Clinical & Translational Oncology Program?
The Program will support a total of 6 Scholars. Two will be selected to begin in July 2014, one in July 2015, two in July 2016, and one in July 2017.

4.    When I complete the K12 Paul Calabresi Career Development for Clinical & Translational Oncology Program will I be guaranteed a faculty position at MUSC?
No. Faculty positions are not guaranteed upon completion of the program.

5.    If I have held previous grant funding, am I eligible to apply?
Ineligible individuals include current and former principal investigators on NIH research project grants, comparable individual career development awards (e.g., K01, K07, K08, K23, K25) equivalent non-PHS peer-reviewed research grants that are over $100,000 direct costs per year, or project leaders on sub-projects of program project (P01) or center (P50) grants. Former principal investigators of NIH Small Grants (R03) or Exploratory/Developmental Grants (R21) remain eligible.

6.    What is patient-oriented research?
Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects.  Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual.  Patient-oriented research includes:

A.         Mechanisms of human disease,

B.         Therapeutic interventions,

C.         Clinical trials,

D.         Development of new technologies,

E.         Epidemiologic and behavioral studies, or

F.          Outcomes research and health services research.

7.    What is the timeline for the application process?
Applications are typically due the first week of January. Internal reviews and interviews will take place in January and February. The selected Scholars will be announced March 1 and begin the program on July 1.

8.    Non-MUSC faculty eligible to apply?
Yes. Non-MUSC faculty are eligible to apply.

9.    Are Associate Professors eligible to apply?
The MUSC K12 is primarily targeted to new Assistant Professors; only under exceptional circumstances would an Associate Professor be considered. If you are an Associate Professor who is interested in applying, please contact Dr. Michael Lilly to discuss your eligibility.


* This website is best viewed in Firefox or Chrome internet browsers.